Waldemar R. Pruzanski
#154,821
Most Influential Person Now
Waldemar R. Pruzanski's AcademicInfluence.com Rankings
Waldemar R. Pruzanskibiology Degrees
Biology
#11865
World Rank
#15294
Historical Rank
Molecular Biology
#1871
World Rank
#1900
Historical Rank
Neuroscience
#1953
World Rank
#2009
Historical Rank
Biochemistry
#1986
World Rank
#2127
Historical Rank
Download Badge
Biology
Waldemar R. Pruzanski's Degrees
- PhD Biochemistry University of California, Berkeley
- Bachelors Chemistry University of California, Berkeley
Why Is Waldemar R. Pruzanski Influential?
(Suggest an Edit or Addition)Waldemar R. Pruzanski's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. (1989) (510)
- Phospholipase A2--a mediator between proximal and distal effectors of inflammation. (1991) (406)
- Role of secretory phospholipases A2 in the pathobiology of disease. (1986) (367)
- A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains (*) (1995) (358)
- Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. (1993) (246)
- Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. (1991) (227)
- Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. (1985) (192)
- IgD multiple myeloma. Review of 133 cases. (1975) (189)
- Cortisol response to corticotropin and survival in septic shock (1991) (161)
- Biologic activity of cold-reacting autoantibodies (second of two parts). (1977) (134)
- Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. (1992) (132)
- Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. (2000) (121)
- Biologic Activity of Cold-Reacting Autoantibodies (1977) (119)
- Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse. (1988) (119)
- B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). (1982) (114)
- The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. (1989) (112)
- Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid. (1985) (107)
- Plasma Cell Neoplasia with Peripheral Polyneuropathy: A STUDY OF FIVE CASES AND A REVIEW OF THE LITERATURE (1980) (107)
- Acute lung injury induced by phospholipase A2. Structural and functional changes. (1991) (105)
- Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. (1998) (94)
- Azathioprine in rheumatoid arthritis. A double-blind, cross over study. (1973) (93)
- Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. (1996) (89)
- Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. (1988) (87)
- Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. (2005) (84)
- Amyloid arthritis simulating rheumatoid disease in five patients with multiple myeloma. (1973) (82)
- Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis. (1986) (81)
- Leukemic form of immunocytic dyscrasia (plasma cell leukemia). A study of ten cases and a review of the literature. (1969) (77)
- Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Report on 10 patients and a review of the literature. (1972) (77)
- Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia. (1970) (73)
- Felty's syndrome. Clinical and serological analysis of 34 cases. (1977) (72)
- Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes. (1993) (72)
- Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome. (1993) (71)
- Kappa and lambda light chain disease: survival rates and clinical manifestations (1976) (66)
- Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action. (1991) (65)
- Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors. (1998) (62)
- Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. (1986) (62)
- Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. (1992) (61)
- M components-a review of 1242 cases. (1976) (61)
- Plasma cell neoplasia with osteosclerotic lesions. A study of five cases and a review of the literature. (1979) (60)
- Anaphylactic shock induced by intraarticular injection of methylprednisolone acetate. (1997) (58)
- Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. (1995) (58)
- Suppression of polyclonal immunoglobulins in multiple myeloma: relationship to the staging and other manifestations at diagnosis. (1980) (55)
- The influence of homogeneous cold agglutinins on polymorphonuclear and mononuclear phagocytes. (1975) (52)
- Multiple forms of phospholipase A2 in arthritic synovial fluid. (1989) (51)
- Treatment of plasma cell myeloma with cytotoxic agents. (1975) (49)
- Angioimmunoblastic lymphadenopathy: an immunochemical study. (1976) (47)
- Waldenström's macroglobulinemia: review of 45 cases. (1976) (47)
- Serum and synovial fluid proteins in rheumatoid arthritis and degenerative joint diseases (1973) (46)
- Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activity. (1997) (45)
- Plasma cortisol levels in patients with septic shock. (1991) (44)
- The Diagnostic Value of Lysozyme (Muramidase) Estimation in Biological Fluids (1969) (41)
- Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2. (1998) (40)
- The influence of homogeneous cold agglutinins on human B and T lymphocytes. (1975) (38)
- Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity. (1994) (37)
- Clinical and immunochemical studies of IgM cold agglutinins with lambda type light chains. (1974) (37)
- The influence of lysostaphin on phagocytosis, intracellular bactericidal activity, and chemotaxis of human polymorphonuclear cells. (1983) (36)
- The influence of natural and synthetic cationic substances on phagocytic activity of human polymorphonuclear cells. An alternative pathway of phagocytic enhancement. (1978) (36)
- Induction of circulating group II phospholipase A2 expression in adults with malaria (1992) (34)
- Modulatory activity of chemotherapeutic agents on phagocytosis and intracellular bactericidal activity of human polymorphonuclear and mononuclear phagocytes. (1983) (33)
- Localization and evolution of two human phospholipase A2 genes and two related genetic elements. (1990) (33)
- Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis. (1991) (33)
- Circulating immune complexes in patients with progressive systemic sclerosis. (1982) (32)
- The significance of lysozyme (muramidase) in rheumatoid arthritis. I. Levels in serum and synovial fluid. (1970) (32)
- Concordance of endogenous cortisol and phospholipase A2 levels in gram-negative septic shock: a prospective study. (1988) (32)
- The effect of chemotherapeutic agents on chemotaxis and random migration of human leukocytes. (1985) (31)
- Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis. (1988) (31)
- Thymoma, myasthenia gravis, erythroblastopenic anemia and systemic lupus erythematosus in one patient. (1973) (31)
- Human monoclonal immunoglobulins with antibody-like activity. (1976) (30)
- Phospholipase A2 activity associated with synovial fluid cells. (1988) (30)
- Systemic lupus erythematosus with paraproteinemia. (1984) (29)
- Invasive aspergillosis in a "healthy" patient. (1984) (29)
- Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. (2002) (29)
- Interleukin‐1α stimulates the release of prostaglandin E2 and phospholipase A2 from fetal rat calvarial cells in vitro: Relationship to bone nodule formation (1991) (29)
- Papular mucinosis with IgG(K) M component. (1976) (29)
- Cytotoxic and cytolytic activity of homogeneous cold agglutinins on peripheral blood monocytes. (1977) (28)
- A new human monoclonal cold agglutinin Sa recognizing terminal N- acetylneuraminyl groups on the cell surface (1980) (27)
- Lymphocytotoxic antibodies against peripheral blood B and T lymphocytes in homosexuals with AIDS and ARC. (1983) (27)
- Release of intracellular constituents from rabbit polymorphonuclear leukocytes exposed to soluble and insoluble immune complexes. (1972) (27)
- Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency (1996) (26)
- Persistent cold agglutinins in AIDS and related disorders. (1986) (23)
- Increased serum phospholipase A2 activity in Malawian children with falciparum malaria. (1993) (23)
- Phospholipase A2 activation is the pivotal step in the effector pathway of inflammation. (1990) (23)
- The role of phospholipase A2 in the physiopathology of osteoarthritis. (1991) (22)
- Phospholipase A2 in juvenile rheumatoid arthritis: correlation to disease type and activity. (1994) (22)
- Fulminant gangrene in transient cold agglutinemia associated with Escherichia coli infection. (1985) (22)
- Induction of circulating phospholipase A2 activity by intravenous infusion of endotoxin in patients with neoplasia. (1992) (21)
- Comparative study of phagocytosis and intracellular bactericidal activity of human monocytes and polymorphonuclear cells (1988) (21)
- Inhibition of type I and type II phospholipase A2 by phosphatidyl-ethanolamine linked to polymeric carriers. (1998) (21)
- Hyperviscosity syndrome in a patient with acquired immunodeficiency syndrome. (1989) (21)
- Synthesis and release of phospholipase A2 by unstimulated human articular chondrocytes. (1990) (21)
- Association of hyperphospholipasemia A2 with multiple system organ dysfunction due to salicylate intoxication. (1993) (21)
- IgD plasma cell neoplasia: clinical manifestations and characteristic features. (1970) (20)
- Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2. (2007) (20)
- Abnormal proteinuria in malignant diseases. (1970) (20)
- Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes. (1995) (19)
- Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock (1986) (19)
- Enzymatic activity and distribution of phospholipase A2 in human cartilage. (1991) (19)
- Synovial fluid examination for the diagnosis of amyloidosis. (1973) (19)
- Immunological and physicochemical studies of IgA1 (delta) cryogelglobulinaemia. (1973) (19)
- M components associated with lymphoma: a review of 62 cases (1976) (19)
- The changing pattern of diseases associated with M components. (1972) (18)
- Biologic activity of cold-reacting autoantibodies (first of two parts). (1977) (18)
- Functional characterization of the cells in chronic neutrophilic leukemia (1982) (18)
- Clinical manifestations of multiple myeloma: relation to class and type M component. (1976) (17)
- Phase composition of lipoprotein SM/cholesterol/PtdCho affects FA specificity of sPLA2s This work was supported in part by grants-in-aid from the Heart and Stroke Foundation of Ontario, Canada. Published, JLR Papers in Press, June 27, 2008. (2008) (16)
- Soluble phospholipase A2 in human pathology: clinical-laboratory interface. (1990) (16)
- Lymphocytotoxic and phagocytotoxic activity in progressive systemic sclerosis. (1983) (15)
- A predictive model for the clearance of soluble phospholipase A2 during septic shock. (1991) (15)
- Hepatitis G and hepatitis C RNA viruses coexisting in cryoglobulinemia. (1998) (15)
- Release of lysosomal enzymes from human polymorphonuclear leukocytes by soluble intermediate immune complexes. (1978) (14)
- Renal handling of endogenous lysozyme in man. (1977) (14)
- Mitogenic Effect of Lipoproteins on Human Vascular Smooth Muscle Cells: The Impact of Hydrolysis by gr II A Phospholipase A2 (2001) (14)
- A new human monoclonal cold agglutinin Sa recognizing terminal N-acetylneuraminyl groups on the cell surface. (1980) (14)
- Induction of TNF-alpha and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritis. (1995) (13)
- Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin (1992) (13)
- Polymyositis in a patient with multiple neoplasms. (1976) (13)
- Amyloid lymphadenopathy. (1976) (13)
- Letter: Lysozyme in Crohn's disease. (1975) (12)
- Esophageal Candidiasis Associated with Beclomethasone Dipropionate Aerosol Therapy (1988) (12)
- Hyperviscosity and Immunoglobulin Complexes (1974) (12)
- The Role of Phospholipase A2 in Interleukin-1α-mediated Inhibition of Mineralization of the Osteoid Formed by Fetal Rat Calvaria Cells in vitro (1993) (12)
- Lysozyme in rheumatic diseases. (1972) (12)
- Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids (1992) (12)
- Coordinate expression of group II phospholipase A2 and the acute‐phase proteins haptoglobin (HP) and α1‐anti‐chymotrypsin (ACH) by HepG2 cells (1997) (11)
- Should tetracyclines be used in arthritis? (1992) (11)
- Structural and immunological studies of two IgGl-λ myeloma proteins from a single patient (1972) (11)
- Inhibition of human group II phospholipase A2 by C-reactive protein in vitro. (1995) (11)
- Heterogeneity of cold- and warm-reacting cytotoxins against lymphocytes, granulocytes, and monocytes in rheumatic diseases. (1978) (11)
- Bacteriolytic and bactericidal activity of sera and synovial fluids in rheumatoid arthritis and in osteoarthritis. (1974) (10)
- Kappa and lambda light chain disease: survival rates and clinical manifestations. (1976) (10)
- Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes (1991) (10)
- Pr and Gd antigens on human B and T lymphocytes and phagocytes. (1980) (9)
- Antinucleic acid autoantibody responses of normal human origin: antigen specificity and idiotypic characteristics compared to patients with systemic lupus erythematosus and patients with monoclonal IgM. (1987) (9)
- Viscosity and hyperviscosity: application of hemorheological concepts to rheumatology. (1985) (9)
- Treatment of inflammatory myopathy with intravenous gamma globulin (1995) (9)
- Cystinuria--report of 56 cases. (1965) (9)
- Third Decennial Review Conference: cell, tissue, and organ culture. Gene expression and regulation in cultured cells. (1979) (9)
- Rheumatological disorders and monoclonal gammopathy--a new syndrome? (1987) (9)
- Phospholipase A2 and inflammation. (1989) (8)
- Bactericidal and bacteriolytic activity of leukemic sera. (1973) (8)
- Microtubule depolymerization selectively down-regulates the synthesis of proinflammatory secretory nonpancreatic phospholipase A2. (1997) (8)
- Heterogeneity of IgM/IgG cryocomplexes: immunological-clinical correlation. (1975) (8)
- Bacteriolytic and bactericidal activity in monocytic and myelomonocytic leukemia with hyperlysozymemia. (1973) (8)
- IgG-1(κ) M component after bone marrow transplantation (1973) (8)
- Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathy. (1981) (8)
- Biological activity of lymphocytotoxic antibodies in Graves’ disease and Hashimoto’s thyroiditis (1984) (8)
- Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma — the relationship to Sia test and to concentration of M component (1976) (8)
- Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2 (1986) (8)
- Influence of chemotherapeutic agents on the antibacterial activity of normal and leukemic sera. (1974) (7)
- Modulation of phagocytosis and intracellular bactericidal activity of polymorphonuclear and mononuclear cells by cationic proteins from human granulocytes: Alternative pathway of phagocytic enhancement (1984) (7)
- The role of intravenous infusions of gamma globulin in the therapy of polymyositis and dermatomyositis. (1994) (7)
- Biochemical characterization of amyloid derived from the variable region of the kappa light chain subgroup III. (1990) (7)
- Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock? (1988) (7)
- Bacteriolytic and bactericidal activity of maternal and cord sera. Relationship to complement, lysozyme, transferrin, and immunoglobulin levels. (1972) (6)
- Multiple myeloma with discordant M components in the serum and CSF. (1981) (6)
- Recognizing and treating plasma cell neoplasia. (1968) (6)
- Modulation of phagocytosis and bactericidal activity of human polymorphonuclear and mononuclear phagocytes by antiarthritic agents. (1983) (6)
- Immunochemical and physical studies of the Sia test (1976) (6)
- Leptospira canicola infection: report of 81 cases and review of the literature. (1963) (6)
- Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A2 (sPLA2) (2017) (6)
- Interleukin-6 and phospholipase A2 in sepsis [letter; comment] (1990) (5)
- Cryptic cold agglutinin activity of monoclonal macroglobulins (1987) (5)
- Induction of Secretory Phospholipase A2 Confirms the Systemic Inflammatory Nature of Adjuvant Arthritis (1998) (5)
- Influence of neutrophil cationic proteins on generation of superoxide by human polymorphonuclear cells during phagocytosis (1987) (5)
- Takatsuki syndrome: a reversible multisystem plasma cell dyscrasia. (1986) (5)
- Modulation of locomotor activity of polymorphonuclear cells by cationic substances and cationic lysosomal fractions from human neutrophils (1985) (5)
- Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts (1995) (5)
- IgG-1(kappa) M component after bone marrow transplantation. (1973) (4)
- Suppression of chemotactic activity of human polymorphonuclears by monoclonal IgMs with and without biological activity (1986) (4)
- Cytotoxic activity of cerebrospinal fluids (CSF's) against lymphocytes and phagocytes: comparison of normal and systemic lupus erythematosus CSF's. (1979) (4)
- 38 – Lysozyme Production and Abnormalities in Rheumatic Diseases* (1974) (4)
- γ3-Heavy-chain disease (γ3-HCD) in a young patient with Down syndrome. Study of peripheral blood lymphocytes and of susceptibility to infection (1979) (4)
- Influence of agents with immunomodulating activity on phagocytosis and bactericidal function of human polymorphonuclear cells. (1983) (3)
- Novel Molecular Approaches to Anti-Inflammatory Therapy (1995) (3)
- Anomalous urinary proteins in patients with serum M-components. (1971) (3)
- Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X. (2016) (3)
- Impact of intravenous infusions of low and high doses of gamma globulins (IVIG) on phagocytic functions in adults with primary humoral immunodeficiency (1994) (3)
- Influence of cationic superoxide generation enhancing protein (SGEP) on phagocytic and intracellular bactericidal activity of human polymorphonuclear cells (1988) (3)
- Phospholipase A2 in articular cartilage. (1990) (3)
- Compartmental heterogeneity of soluble phospholipases A (1990) (3)
- Anemia, splenomegaly and hyperviscosity syndrome. (1980) (3)
- Studies on Human Myeloma Proteins with Antibody-Like Activity (1971) (3)
- Modulation of functional activity of human polymorphonuclear and mononuclear phagocytes by intravenous gamma globulin (1989) (2)
- Intestinal and cutaneous hemangiomatosis (1963) (2)
- Interleukin-6 and phospholipase A2 in sepsis. (1990) (2)
- 111 THE EFFECT OF LIPID PEROXIDATION ON HUMAN SECRETORY PHOSPHOLIPASE A2 (sPLA2)-MEDIATED DEGRADATION OF CELL MEMBRANES (1995) (2)
- Malabsorption syndrome with IgG(lambda) M component: response to chemotherapy. (1976) (2)
- Serum phospholipase A2 values and septic shock. (1991) (2)
- Amyloidogenesis-theories and facts. (1977) (2)
- Immunoglobulins in diagnosis and monitoring of neoplasia. (1990) (2)
- Diverse activity of human secretory phospholipases A2 on the migration of human vascular smooth muscle cells (2015) (2)
- Hypophospholipasemia A2 in systemic sclerosis. (1990) (2)
- Inter-Relationship of Phospholipase A2 and Lipid Peroxidation in Multisystem Organ Failure in Septic Shock (1997) (2)
- Serum and urinary proteins and renal function in chronic myelogenous leukemia (1972) (2)
- Induction of circulating phospholipase A2 by intravenous administration of recombinant human tumour necrosis factor (1992) (2)
- Biologic role of lymphocytes. (1977) (2)
- Lymphocytotoxins in vasculitis. Correlation with clinical manifestations and laboratory variables. (1986) (2)
- Epoxy Fatty Acids (2017) (2)
- Phospholipase A2 and the Pathogenesis of Multisystem Organ Failure in Experimental and Clinical Endotoxin Shock (1994) (1)
- Hydrolysis of glycerophosphocholine epoxides by human group IIA, V, and X secretory phospholipases A2. (2021) (1)
- Serum Phopholipase A2 Values and Spetic Shock (1991) (1)
- Secretory Nonpancreatic Phospholipase A2 (sPLA2) as a Mediator of Inflammation (1997) (1)
- Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis (1977) (1)
- Inhibition of the activity of pro-inflammatory secretory phospholipase A2 by acute phase proteins (1996) (1)
- Phospholipase A 2 : quo vadis ? (2005) (1)
- Reactivity of cold agglutinins with subsets of human lymphocytes of various origins. (1982) (1)
- Hydrolysis of polyhydroxy polyunsaturated fatty acid-glycerophosphocholines by Group IIA, V, and X secretory phospholipases A2. (2022) (1)
- New antigenic determinant (Sa) on human lymphocytes and phagocytes (1981) (1)
- Secretory PLAA2-Deficient and Transgenic Mice in Phospholipase A2 Research (1997) (1)
- THU0551 Secretory Phospholipases as Mediators of Inflammatory and Proatheromatous Changes in Rheumatic Diseases (2014) (1)
- Effects of bioflavonoids on phagocytosis, intracellular bactericidal activity and chemotaxis of human polymorphonuclear cells. (1983) (1)
- SERUM PHOSPHOLIPASE A2 VALUES AND SEPTIC SHOCK. REPLY (1991) (1)
- Phagocytic enhancement of granulocytes and monocytes by cationic proteins from human polymorphonuclear leukocytes. (1982) (1)
- Long‐term side effects of azathioprine (1974) (1)
- Renal amyloidosis in rheumatoid arthritis. (2007) (1)
- Gamma 3-heavy-chain disease (gamma 3-HCD) in a young patient with Down syndrome. Study of peripheral blood lymphocytes and of susceptibility to infection. (1979) (1)
- Lymphocytotoxins in progressive systemic sclerosis. (1983) (0)
- Structural and immunological studies of two IgGl-lambda myeloma proteins from a single patient. (1972) (0)
- Autoxidation of Plasma Lipids, Generation of Bioactive Products, and Their Biological Relevance (2015) (0)
- Inflammatory Models (2014) (0)
- III international conference on osteoporosis in men May 12-14, 2005, Genova, Italy. (2006) (0)
- Editorial: Thewayahead. WorldRheumatism Yearandafter Behcet's syndrome in32patients inYorkshire (1977) (0)
- EXOTOXINS INDUCE PROINFLAMMATORY Gr IIA sPLA2 IN NOCENT CELLS.: 142 (1999) (0)
- Preface (1994) (0)
- Electronic storage of LC/ESI‐MS total ion current profiles of total lipid extracts and multidimensional lipidomic analysis of plasma lipoproteins (2014) (0)
- Influence of monoclonal igm cold agglutinins on adhesiveness, phagocytosis, and bactericidal activity on human granulocytes and monocytes (1989) (0)
- [Editorial: Clinical immunology]. (1976) (0)
- Humoral factors: edited by E. Sim, Oxford University Press, 1993. £27.50/$46.95 (xxiv + 373 pages) ISBN 0 19 963336 3 (1994) (0)
- Tenidap in rheumatoid arthritis: comment on the article by Blackburn et al. (1996) (0)
- Proceedings of the Second Update on Psoriatic Disease, University Federico II Congress Center, July 6–7, 2011, Naples, Italy. (2012) (0)
- Editorial: Clinical immunology. (1976) (0)
- Serum and Synovial Fluid Proteins in Rheumatoid Arthritis (1972) (0)
- SAT0030 Release of Secondary Mediators of Inflammation by Human Secretory Phospholipases A2 (SPLA2's) (2015) (0)
- Role of Calcitonin in Osteosclerosis of Myeloma?-Reply (1980) (0)
- Renal amyloidosis in rheumatoid arthritis. Author's reply (2007) (0)
- Editorial: Hyperviscosity and immunoglobulin complexes. (1974) (0)
- Bactericidal and Bacteriolytic Activity of Leukemic (2006) (0)
- Paraproteins in disease : investigation of plasma cell dyscrasia (1985) (0)
- Cytokines in collagen disease-related atherogenesis. (2006) (0)
- The Release of Acid Hydrolases and Cationic Protein from Polymorphonuclear Leucocytes Exposed to Immune Complexes (1972) (0)
- Clinical immunology : proceedings of the 1st IUIS Conference on Clinical Immunology, Toronto, 6-11 July 1986 (1987) (0)
- Studies on the release of phlogistic agents from polymorphonuclear leukocytes exposed to immune complexes. (1972) (0)
- Clinical immunology: its role in medicine and future in Canada. (1983) (0)
- I/i antigens on the peripheral blood lymphocytes in Graves disease. (1979) (0)
- Letter: Long-term side effects of azathioprine. (1974) (0)
- Shoulder pads in amyloid arthropathy. (1973) (0)
- Lysozyme (Muramidase) in Rheumatoid Arthritis (1972) (0)
- Diverse activity of human secretory phospholipases A2 on the migration of human vascular smooth muscle cells (2015) (0)
- Physicochemical, Immunological and Structural Studies on Two M-Components from a Single Individual (1971) (0)
- Detection of abnormal proteins in malignant plasmalymphocytic diseases. (1978) (0)
- Preface. (1994) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Waldemar R. Pruzanski?
Waldemar R. Pruzanski is affiliated with the following schools:
